MetLife Investment Management LLC Has $16.77 Million Position in HCA Healthcare, Inc. $HCA

MetLife Investment Management LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 48,529 shares of the company’s stock after selling 1,790 shares during the period. MetLife Investment Management LLC’s holdings in HCA Healthcare were worth $16,769,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the first quarter worth approximately $26,000. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the first quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC grew its holdings in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC grew its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after purchasing an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. grew its holdings in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.2%

Shares of HCA stock opened at $404.87 on Monday. The stock has a market cap of $94.74 billion, a P/E ratio of 17.02, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a fifty day moving average price of $373.91 and a 200 day moving average price of $354.23. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Bank of America cut HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 price objective for the company. in a research report on Wednesday, July 16th. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research report on Wednesday, July 16th. Finally, Morgan Stanley reduced their price objective on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $398.58.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.